Shariah compliance overview
Not HalalCelldex Therapeutics, Inc. (CLDX) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. is a biopharmaceutical company dedicated to developing antibody-based treatments, specifically monoclonal and bispecific antibodies, for a range of diseases. Their pipeline features therapeutic candidates aimed at both inflammatory conditions and various forms of cancer.
Celldex Therapeutics, Inc. (CLDX) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity.
- Business Activity
- 95.02%Limit 5%Fail
- Interest-bearing debt
- 0.00%Limit 30%Pass
- Interest-bearing securities and assets
- 26.58%Limit 30%Pass
- Dividend purification
- 95.02%Share of dividends to give to charityPurification calculator
Last updated: Oct 22, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Celldex Therapeutics, Inc. (CLDX). Current Akinda screening label: Not Halal.
